Stay updated on Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    New document revision v3.3.4 replaces v3.3.3, a minor metadata update with no change to core study content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:14:51.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page adds a Locations section showing three study sites (Duarte, CA; Aurora, CO; Philadelphia, PA) and their institutions, and displays a Revision: v3.3.3 tag.
    Difference
    0.4%
    Check dated 2025-12-23T17:36:51.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-24T21:10:27.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and NIH operating status was removed, not affecting the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T18:31:44.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page. The content and structure appear consistent with prior versions.
    Difference
    0.4%
    Check dated 2025-11-03T13:43:29.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Update adds a government operating-status notice and increments version to v3.2.0; it removes the Mature T-cell and NK-cell non-Hodgkin lymphoma resource (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T01:46:43.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.